Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma studyWeili Sun, James A. Whitlock, Theodore W. Laetsch et al.|Leukemia|2018Cited by 117
Treatment‐related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemiaWeili Sun, Alan S. Wayne, Etan Orgel et al.|Pediatric Blood & Cancer|2016Cited by 29
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJulio C. Barredo, Maria Luisa Sulis, Julia Glade Bender et al.|Pediatric Hematology and Oncology|2020Cited by 24
The UK ALLR3 Chemotherapy Regimen for Relapsed/Refractory Acute Lymphoblastic Leukemia of Childhood: A Multi-Institutional Retrospective Study of Treatment Related Adverse EventsWeili Sun, Alan S. Wayne, Alison Smith et al.|Blood|2014Cited by 4